Patent details

EP1898904 Title: MODIFIED RELEASE 1-Ö(3-HYDROXY-ADAMANT-1-YLAMINO)-ACETYLÜ-PYRROLIDINE-2(S)-CARBONITRILE FORMULATION

Basic Information

Publication number:
EP1898904
PCT Application Number:
PCT/US/2006/022416
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP067726539
PCT Publication Number:
WO/2006/135723
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MODIFIED RELEASE 1-Ö(3-HYDROXY-ADAMANT-1-YLAMINO)-ACETYLÜ-PYRROLIDINE-2(S)-CARBONITRILE FORMULATION
French Title of Invention:
FORMULATION DE 1-Ý(3-HYDROXY-ADAMANT-1-YLAMINO)-ACETYL¨-PYRROLIDINE-2(S)-CARBONITRILE
German Title of Invention:
1-Ö(3-HYDROXY-ADAMANT-1-YLAMINO)-ACETYLÜ-PYRROLIDIN-2(S)-CARBONITRIL-FORMULIERUNG MIT MODIFIZIERTER FREISETZUNG
SPC Number:

Dates

Filing date:
08/06/2006
Grant date:
07/10/2009
EP Publication Date:
07/10/2009
PCT Publication Date:
21/12/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/03/2008
EP B1 Publication Date:
07/10/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/06/2018
Expiration date:
08/06/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/06/2006
 
 

Name:
NOVARTIS AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:
Novartis Pharma GmbH
Address:
Brunner Strasse 59, 1230 Vienna, Austria (AT)

Inventor

1

Name:
KOWALSKI James
Address:
United States (US)

2

Name:
LAKSHMAN Jay, Parthiban
Address:
United States (US)

3

Name:
JOSHI Yatindra
Address:
United States (US)

4

Name:
SERAJUDDIN Abu, T. M.
Address:
United States (US)

Priority

1

Priority Number:
689719 P
Priority Date:
10/06/2005
Priority Country:
United States (US)

2

Priority Number:
690309 P
Priority Date:
14/06/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/40;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
24/05/2017
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
30/10/2018 Outgoing Correspondence 1